Financhill
Back

Bicycle Therapeutics PLC Vs. Builders FirstSource Industry Stock Comparison

Sell
8

BCYC
Bicycle Therapeutics PLC

Last Price:
21.38
Seasonality Move:
10.82%
Sell
49

BLDR
Builders FirstSource

Last Price:
167.00
Seasonality Move:
6.7%
Sell
8
Bicycle Therapeutics PLC (BCYC) is a Sell

Is Bicycle Therapeutics PLC a Buy, Sell or Hold?

  • The current Bicycle Therapeutics PLC [BCYC] share price is $21.36. The Score for BCYC is 8, which is 84% below its historic median score of 50, and infers higher risk than normal.
  • BCYC is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
49
Builders FirstSource (BLDR) is a Sell

Is Builders FirstSource a Buy, Sell or Hold?

  • The current Builders FirstSource [BLDR] share price is $167.05. The Score for BLDR is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • BLDR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

BCYC Stock Price Chart

What is Bicycle Therapeutics PLC's stock price today?

  • The Bicycle Therapeutics PLC share price today is $21.36
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BCYC is experiencing selling pressure, which indicates risk of future bearish movement.

BLDR Stock Price Chart

What is Builders FirstSource's stock price today?

  • The Builders FirstSource share price today is $167.05
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BLDR is experiencing slight selling pressure.

BCYC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.33 Sell
Relative Strength Index (14 RSI): 37.71 Sell
Chaikin Money Flow: -104801 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (22.05 - 23.85) Sell
Bollinger Bands (100): (18.78 - 24.7) Sell

BLDR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -6.4 Sell
Relative Strength Index (14 RSI): 39.78 Sell
Chaikin Money Flow: -337678 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (168.74 - 189.2) Sell
Bollinger Bands (100): (169.66 - 198.36) Sell

BCYC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 22.55 Sell
20-day SMA: 23.01 Sell
50-day SMA: 23.51 Sell
200-day SMA: 20.19 Buy
8-day EMA: 22.37 Sell
20-day EMA: 22.85 Sell
50-day EMA: 22.85 Sell
200-day EMA: 21.61 Sell

BLDR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 167.64 Sell
20-day SMA: 178.45 Sell
50-day SMA: 189.88 Sell
200-day SMA: 158.52 Buy
8-day EMA: 170.04 Sell
20-day EMA: 176.53 Sell
50-day EMA: 182.8 Sell
200-day EMA: 161.7 Buy

Bicycle Therapeutics PLC Earnings Growth & BCYC Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.19 per share, an increase next quarter of $0.11 per share, an increase this year of $0.83 per share, and a decrease next year of $0.58 per share.

Builders FirstSource Earnings Growth & BLDR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.49 per share, a decrease this year of $0.87 per share, and an increase next year of $1.33 per share.

Bicycle Therapeutics PLC Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Builders FirstSource Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):